Developments include cell-based and recombinant DNA technologies. The global influenza vaccine market is projected to cross $14b by 2032, according to DelveInsight. The sector’s expansion is ...

BMS’ Breyanzi and Amgen’s Blincyto will now be available to patients in England with certain types of blood cancer.

Roche has put forward a new approach to genetic analysis, which it describes as sequencing-by-expansion—a proprietary method that pulls apart the DNA molecule and amplifies the signal of | Roche said ...

Researchers have discovered and analyzed a rare but serious side effect of an innovative form of blood cancer therapy. The ...

Ridgefield, Conn., U.S., and Ingelheim, GermanyZongertinib would be the first orally administered, targeted therapy for previously treated ...

The addition of epcoritamab-bysp to standard chemotherapy significantly improved response and survival for patients with ...

A GROUNDBREAKING study has revealed how the human immune system evolves across the lifespan, uncovering age-specific changes ...

Researchers have discovered the mechanism that helps regulate the immune system’s response to helminth infection.

Among adults with relapsed or refractory indolent B-cell non-Hodgkin lymphoma, the phase 2 TRANSCEND FL trial met its primary ...

Auron Therapeutics has raised a $27 million Series B financing that it will use to initiate clinical development of its lead experimental drug, AUTX-703, in blood cancers.

Leaked data showed that Pfizer’s mevrometostat has strong therapeutic potential in metastatic castration-resistant prostate ...

A study published in Science Advances reveals a novel strategy that allows tumors to evade the body's immune response ...